Content provided by PatSnap | 15-Jun-2022
| White Paper
More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging....
Content provided by PerkinElmer | 01-Jun-2021
| White Paper
The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...
Content provided by Catalent | 24-Aug-2015
| White Paper
Viral clearance studies are mandated prior to entering clinical trials and for commercial launch of biopharmaceuticals. These studies are a key component...
Content provided by Catalent | 26-Jan-2015
| White Paper
Assessment of biosimilar molecules requires an orthogonal analytical approach. Any one particular analytical technique is not able to fully define the...
